Evidence map›Paper›PMID 31861956›Full record

ArticleMaterials (Basel, Switzerland)2019

Evaluation of a Zn-2Ag-1.8Au-0.2V Alloy for Absorbable Biocompatible Materials.

Ping Li, Christine Schille, Ernst Schweizer, Evi Kimmerle-Müller, Frank Rupp, Xingting Han, Alexander Heiss, Andreas Richter, Claudia Legner, Ulrich E Klotz and 2 more

Open access · goldAbstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Recent Advances in Research on Antibacterial Metals and Alloys as Implant Materials.Frontiers in cellular and infection microbiology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Ping LiSection Medical Materials Science and Technology, University Hospital Tübingen, Osianderstrasse 2-8, 72076 Tübingen, Germany.
Christine SchilleSection Medical Materials Science and Technology, University Hospital Tübingen, Osianderstrasse 2-8, 72076 Tübingen, Germany.
Ernst SchweizerSection Medical Materials Science and Technology, University Hospital Tübingen, Osianderstrasse 2-8, 72076 Tübingen, Germany.
Evi Kimmerle-MüllerSection Medical Materials Science and Technology, University Hospital Tübingen, Osianderstrasse 2-8, 72076 Tübingen, Germany.
Frank RuppSection Medical Materials Science and Technology, University Hospital Tübingen, Osianderstrasse 2-8, 72076 Tübingen, Germany.
Xingting HanSection Medical Materials Science and Technology, University Hospital Tübingen, Osianderstrasse 2-8, 72076 Tübingen, Germany.ORCID 0000-0001-5510-0197
Alexander HeissResearch Institute for Precious Metals and Metals Chemistry (fem), Katharinenstrasse 17, 73525 Schwäbisch Gmünd, Germany.ORCID 0000-0002-6033-6636
Andreas RichterResearch Institute for Precious Metals and Metals Chemistry (fem), Katharinenstrasse 17, 73525 Schwäbisch Gmünd, Germany.
Claudia LegnerResearch Institute for Precious Metals and Metals Chemistry (fem), Katharinenstrasse 17, 73525 Schwäbisch Gmünd, Germany.
Ulrich E KlotzResearch Institute for Precious Metals and Metals Chemistry (fem), Katharinenstrasse 17, 73525 Schwäbisch Gmünd, Germany.
Jürgen Geis-GerstorferSection Medical Materials Science and Technology, University Hospital Tübingen, Osianderstrasse 2-8, 72076 Tübingen, Germany.
Lutz ScheidelerSection Medical Materials Science and Technology, University Hospital Tübingen, Osianderstrasse 2-8, 72076 Tübingen, Germany.ORCID 0000-0001-6833-0899
Forschungsinstitut für Edelmetalle und Metallchemie · DE

Funding

Allianz Industrie Forschung KF2342806CK2China Scholarship Council 201608440274
6 · The paper itself

Abstract

Zinc (Zn) and Zn-based alloys have been proposed as a new generation of absorbable metals mainly owing to the moderate degradation behavior of zinc between magnesium and iron. Nonetheless, mechanical strength of pure Zn is relatively poor, making it insufficient for the majority of clinical applications. In this study, a novel Zn-2Ag-1.8Au-0.2V (wt.%) alloy (Zn-Ag-Au-V) was fabricated and investigated for use as a potential absorbable biocompatible material. Microstructural characterization indicated an effective grain-refining effect on the Zn alloy after a thermomechanical treatment. Compared to pure Zn, the Zn-Ag-Au-V alloy showed significantly enhanced mechanical properties, with a yield strength of 168 MPa, an ultimate tensile strength of 233 MPa, and an elongation of 17%. Immersion test indicated that the degradation rate of the Zn-Ag-Au-V alloy in Dulbecco's phosphate buffered saline was approximately 7.34 ± 0.64 μm/year, thus being slightly lower than that of pure Zn. Biocompatibility tests with L929 and Saos-2 cells showed a moderate cytotoxicity, alloy extracts at 16.7%, and 10% concentration did not affect metabolic activity and cell proliferation. Plaque formation in vitro was reduced, the Zn-Ag-Au-V surface inhibited adhesion and biofilm formation by the early oral colonizer

Indexed as

absorbablebioactivitybiocompatibilitybiocompatible materialsbiofilmzinc

Identifiers

PMID31861956
PMCPMC6981962
OpenAlexW2995972137

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.